MedRhythms, Inc. (“MedRhythms”) is a digital therapeutics company using sensors, software, and music to deliver Auditory-Motor Entrainment (“AME”) therapy to chronic stroke survivors. Rhythmic auditory stimulation unconsciously synchronizes with the motor system, leading to improvements in walking speed, gait symmetry, and fall risk, ultimately improving independence and quality of life for patients. This project supported MedRhythm’s ongoing research, development, and product commercialization efforts and provided working capital.